|
Dec 21
|
Here’s Why Teva Pharmaceutical Industries Limited (TEVA) Rose in Q3
|
|
Dec 7
|
FTC warns pharma companies on excessive drug patenting
|
|
Dec 6
|
New Post Hoc Phase 3 Data Analysis Shows AJOVY® (fremanezumab) Reduced Migraine Attacks in Adults with Migraine and Co-morbid Obesity
|
|
Nov 30
|
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
|
|
Nov 27
|
Teva Pharmaceutical upgraded to 'Buy' at UBS
|
|
Nov 27
|
Roku upgraded, Lucid Group downgraded: Wall Street's top analyst calls
|
|
Nov 27
|
Teva Pharmaceutical: Long-Term Cash Cow
|
|
Nov 27
|
Midday movers: Affirm, Amazon, and More
|
|
Nov 27
|
Roku raised to Buy, YPF extends gains following upgrade: 4 big analyst picks
|
|
Oct 10
|
UPDATE 1-Drugmaker Teva does not see big impact on business from Israel-Hamas war
|
|
Oct 6
|
Health Care Roundup: Market Talk
|
|
Oct 6
|
Teva to Host Conference Call to Discuss Third Quarter 2023 Financial Results at 8 a.m. ET on November 8, 2023
|
|
Oct 4
|
Teva Pharma Hooks Sanofi In $1.5 Billion Inflammation Deal. But Shares Tumble.
|
|
Oct 4
|
Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease Treatment
|
|
Sep 28
|
Teva Announces Changes to Executive Management Team
|
|
Aug 23
|
TEVA to Pay $225 Million to Settle Price-Fixing Charges (Revised)
|
|
Aug 22
|
Teva Pharma: generics titan attempts to put the stopper in legal problems
|
|
Aug 22
|
TEVA to Pay $250 Million to Settle Price-Fixing Charges
|
|
Aug 21
|
Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges
|
|
Aug 21
|
Teva to pay $225M to settle cholesterol drug price-fixing charges
|